Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, MICKEY NMN | 1 | 61.5% | +50.4% |
| BOWERS, NATHAN ANDREW | 1 | 59.2% | +32.0% |
| SMALL, KATHERINE R | 1 | 65.4% | +29.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17603276 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | SMALL, KATHERINE R | 77d overdue |
| 18237251 | LIPID NANOPARTICLE (LNP) ENCAPSULATION OF MRNA PRODUCTS | HUANG, MICKEY NMN | 3d overdue |
| 17913392 | In Vitro Manufacturing And Purification Of Therapeutic mRNA | BOWERS, NATHAN ANDREW | 6d |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1799 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18237251 | LIPID NANOPARTICLE (LNP) ENCAPSULATION OF MRNA PRODUCTS | HUANG, MICKEY NMN | 1758 | §103 | Non-Final OA | 3d overdue | Pending | Aug 23, 2023 |
| 17913392 | In Vitro Manufacturing And Purification Of Therapeutic mRNA | BOWERS, NATHAN ANDREW | 1799 | §103 | Final Rejection | 6d | Pending | Sep 21, 2022 |
| 17603276 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | SMALL, KATHERINE R | 1633 | §103 | Final Rejection | 77d overdue | Pending | Oct 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial